Envoy Medical, Inc.

Historical 13F Holders

Symbol
COCH
CUSIP
29415V109
All holders as of
Q2 2026
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29415V109 since 12/18/2024, newest first.

Filer % of Class Filed
Nantahala Capital Management, LLC 13G
10.0% 5/15/2026
Event 3/31/2026
Bleichroeder LP 13G
10.0% 5/14/2026
Event 3/31/2026
Ayrton Capital LLC 13G/A Amendment 1
3.1% 5/11/2026
Event 3/31/2026
Glen A. Taylor 13D/A Amendment 1 84.8% 2/17/2026
Event 2/12/2026
Ayrton Capital LLC 13G
7.9% 2/11/2026
Event 12/31/2025
Glen A. Taylor 13D 44.2% 12/8/2025
Event 12/1/2025
Anzu SPAC GP I LLC 13D
11.3% 12/26/2024
Event 9/29/2023

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 13.1 k $8.91 k
2026 Q2 32 25.4 M $19.9 M
2026 Q1 33 17.3 M $11.5 M
2025 Q4 28 1.53 M $1.01 M
2025 Q3 28 2.12 M $1.65 M
2025 Q2 23 2.31 M $3.28 M
2025 Q1 23 2.30 M $3.00 M
2024 Q4 25 2.02 M $2.95 M
2024 Q3 20 1.03 M $3.33 M
2024 Q2 23 1.19 M $2.82 M
2024 Q1 20 1.24 M $4.84 M
2023 Q4 12 2.08 M $3.79 M